DK0456720T3 - Granuleringer med højt ibuprofenindhold - Google Patents

Granuleringer med højt ibuprofenindhold

Info

Publication number
DK0456720T3
DK0456720T3 DK90902888.8T DK90902888T DK0456720T3 DK 0456720 T3 DK0456720 T3 DK 0456720T3 DK 90902888 T DK90902888 T DK 90902888T DK 0456720 T3 DK0456720 T3 DK 0456720T3
Authority
DK
Denmark
Prior art keywords
binder
percent
polyvinylpyrrolidone
granules
ibuprofen
Prior art date
Application number
DK90902888.8T
Other languages
English (en)
Inventor
Larry E Denton
Anil M Salpekar
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of DK0456720T3 publication Critical patent/DK0456720T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK90902888.8T 1989-02-02 1990-01-31 Granuleringer med højt ibuprofenindhold DK0456720T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/306,014 US4911921A (en) 1989-02-02 1989-02-02 High ibuprofen content granulations

Publications (1)

Publication Number Publication Date
DK0456720T3 true DK0456720T3 (da) 1995-08-14

Family

ID=23183358

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90902888.8T DK0456720T3 (da) 1989-02-02 1990-01-31 Granuleringer med højt ibuprofenindhold

Country Status (10)

Country Link
US (1) US4911921A (da)
EP (1) EP0456720B1 (da)
JP (1) JP2556623B2 (da)
AT (1) ATE124257T1 (da)
AU (1) AU629913B2 (da)
CA (1) CA2045680C (da)
DE (1) DE69020541T2 (da)
DK (1) DK0456720T3 (da)
ES (1) ES2076358T3 (da)
WO (1) WO1990008542A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104648A (en) * 1989-02-02 1992-04-14 Mallinckrodt Specialty Chemicals Company High ibuprofen content granulations
US5087454A (en) * 1990-07-30 1992-02-11 American Home Products Corporation Ibuprofen tablet
GB9119052D0 (en) * 1991-09-06 1991-10-23 Boots Co Plc Pharmaceutical compositions
US5191114A (en) * 1991-10-09 1993-03-02 Sage Pharmaceuticals, Inc. Process for enhancing the flow characteristics of ibuprofen
US5310961A (en) * 1993-07-02 1994-05-10 Affinity Biotech, Inc. Neomorphic ibuprofen
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US6251945B1 (en) 1999-01-14 2001-06-26 Knoll Aktiengesellschaft Pharmaceutical mixture comprising a combination of a profen and other active compounds
DE10003757A1 (de) * 2000-01-28 2001-08-02 Knoll Ag Ibuprofen-Wirkstoffzubereitung
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
CZ296100B6 (cs) 2002-04-29 2006-01-11 EGIS Gyógyszergyár Rt. Zpusob prípravy tablet z farmaceuticky aktivních látek majících nevýhodné tabletacní vlastnosti s granulacní kapalinou obsahující mikrokrystalickou celulózu
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
BRPI0512900A (pt) * 2004-06-30 2008-04-15 Albemarle Corp composição farmacêutica compreendendo de ibuprofeno, processo de preparação dos gránulos enriquecidos em ibuprofeno e os gránulos secos feitos por este processo
EP1737847B1 (en) 2004-07-30 2008-06-04 Torrent Pharmaceuticals Ltd Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
DK1884242T3 (da) 2005-05-26 2013-05-06 Dainippon Sumitomo Pharma Co Farmaceutisk sammensætning omfattende lurasidon
CA2577760A1 (en) * 2006-02-27 2007-08-27 Tyco Healthcare Group Lp Pressurized dip coating system
US20070212417A1 (en) * 2006-03-07 2007-09-13 Cherukuri S R Compressible resilient granules and formulations prepared therefrom
US20080069889A1 (en) * 2006-03-07 2008-03-20 Cherukuri S R Compressible resilient granules and formulations prepared therefrom

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3108046A (en) * 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
US4209513A (en) * 1974-02-14 1980-06-24 Burroughs Wellcome Co. Tablet formulation
US4661521A (en) * 1984-04-30 1987-04-28 Mallinckrodt, Inc. Direct tableting acetaminophen compositions
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
US4757090A (en) * 1986-07-14 1988-07-12 Mallinckrodt, Inc. Direct tableting acetaminophen compositions
US4806359A (en) * 1987-04-22 1989-02-21 Mcneilab, Inc. Iburprofen sustained release matrix and process
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen

Also Published As

Publication number Publication date
JP2556623B2 (ja) 1996-11-20
JPH04503069A (ja) 1992-06-04
DE69020541D1 (de) 1995-08-03
ATE124257T1 (de) 1995-07-15
EP0456720A1 (en) 1991-11-21
AU629913B2 (en) 1992-10-15
US4911921A (en) 1990-03-27
WO1990008542A1 (en) 1990-08-09
AU5036990A (en) 1990-08-24
CA2045680C (en) 1997-01-14
ES2076358T3 (es) 1995-11-01
DE69020541T2 (de) 1995-11-02
EP0456720B1 (en) 1995-06-28
CA2045680A1 (en) 1990-08-03

Similar Documents

Publication Publication Date Title
DK0456720T3 (da) Granuleringer med højt ibuprofenindhold
DE3877764D1 (de) Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren.
ATE125155T1 (de) Niedrigdosierte getrocknete pharmazeutische präparate.
DE59307753D1 (de) Tabletten, Granulate und Pellets mit hohem Gehalt an Wirkstoffen für hochkonzentrierte, feste Darreichungsformen
TR200200688T2 (tr) Doğrudan tablet şeklinde preslenebilen ultra ince asetaminofen terkipleri ve bu terkiplerin üretim prosesi
DK0698389T3 (da) Matrix med reguleret frigivelse til farmaceutiske præparater
DE3879080D1 (de) Pharmazeutische matrix mit verzoegerter freisetzung und verfahren.
UA5328A1 (uk) Спосіб одержання таблеток
DE69001488D1 (de) Mittel auf gemfibrozilbasis mit modifizierter freigabe.
GR3006498T3 (da)
GR900300172T1 (en) Processes for the preparation of pharmaceutical compositions containing bromocriptine having high stability and related products
DE69907717D1 (de) Pharmazeutische formulierung in form eines trockenen pulvers
IL82065A0 (en) Pellet-containing delayed release pharmaceutical and veterinary composition and its preparation
FR2656772B1 (fr) Procede d'incorporation dans des pellets de principes actifs proteges contre la degradation dans la panse des ruminants.
JPS5726615A (en) Improving method for absorbability of slightly soluble drug
JPS5781409A (en) External plaster
DE69214333D1 (de) Arzneizubereitung mit hohem Gehalt an Ibuprofenlysinat
Hontz Assessment of Selected formulation and processing variables in fluid bed granulation
TH13475A (th) สูตรผสมทางเภสัชกรรม
KR880012206A (ko) 구강질환 치료 조성물